Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/5415
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRao, RS-
dc.contributor.authorPrakash, A-
dc.contributor.authorMedhi, B-
dc.date.accessioned2009-07-21T11:37:22Z-
dc.date.available2009-07-21T11:37:22Z-
dc.date.issued2009-08-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/5415-
dc.description625-634en_US
dc.description.abstractEpilepsy is a common health problem. Although variety of factors influence the incidence and prevalence of seizures, cytokines are considered to play an important role in seizures. Cytokines are also known to be involved in other neurodegenerative disorders. Proinflammatory cytokines like IL-1, IL-6, TNF- and growth factor vascular endothelial growth factor (VEGF) as well as anti-inflammatory cytokine IL-10 and related molecules have been described in CNS and plasma of experimental models of seizures and clinical cases of epilepsy. There are reports suggesting more predispositions to seizures during inflammatory conditions like colitis, pneumonia and rheumatoid arthritis. These inflammatory cytokines and growth factors are also known to have dual roles in affecting seizure susceptibility. It remains to be seen if cytokine modulators can be therapeutically exploited for patients with inflammatory disorder and suffering from epilepsy.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.sourceIJEB Vol.47(08) [August 2009]en_US
dc.subjectAntiepileptic drugsen_US
dc.subjectCytokinesen_US
dc.subjectEpilepsyen_US
dc.subjectInflammationen_US
dc.titleRole of different cytokines and seizure susceptibility: A new dimension towards epilepsy researchen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.47(08) [August 2009]

Files in This Item:
File Description SizeFormat 
IJEB 47(8) 625-634.pdf189.46 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.